v3.26.1
Out-license Agreements - Additional Information (Detail) - USD ($)
$ in Thousands
 1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Aug. 31, 2024
Jul. 31, 2024
Mar. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Oct. 31, 2021
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2022
License Collaboration And Manufacturing Agreements [Line Items]                      
Proceeds from sale of future royalties, gross                 $ 31,000    
Revenue             $ 630 $ 17,575 1,146 $ 115,724  
Deferred revenue, revenue recognized                 0    
Additional Territory [Member]                      
License Collaboration And Manufacturing Agreements [Line Items]                      
Deferred revenue             800   800    
Pierre Fabre Commercialization Agreement                      
License Collaboration And Manufacturing Agreements [Line Items]                      
Aggregate milestone payments entitle to receive upon achieving certain regulatory and commercial milestones         $ 308,000           $ 308,000
Payments received from sale of inventory $ 15,500                    
Determined upfront payment constituted entire consideration included in transaction price           $ 45,000          
Development or sales-based milestone payments earned or received         40,000 30,000          
HCRx Agreement [Member]                      
License Collaboration And Manufacturing Agreements [Line Items]                      
Proceeds from sale of future royalties, gross         $ 31,000       $ 31,000   $ 31,000
Minimum cash repayment         185.00%       185.00%    
Maximum cash repayment         250.00%       250.00%    
AR Commercialization Agreement [Member]                      
License Collaboration And Manufacturing Agreements [Line Items]                      
Reduce Milestone Payment                 $ 31,000    
Milestone payments             308,000   308,000    
Additional milestone payments                 15,000    
Aggregate milestone payments entitle to receive upon achieving certain regulatory and commercial milestones             556,000   556,000    
Royalty eligible to receive term after first commercial sale       12 years              
Determined upfront payment constituted entire consideration included in transaction price           $ 20,000          
Development or sales-based milestone payments earned or received   $ 20,000 $ 20,000                
Costs Incurred Relatedto Performance Obligations Includedin R&D             $ 200 $ 4,000 200 $ 11,100  
AR Commercialization Agreement [Member] | Additional Territory [Member]                      
License Collaboration And Manufacturing Agreements [Line Items]                      
Maximum potential milestone payments                 31,000    
AR Commercialization Agreement [Member] | All Milestones [Member] | Additional Territory [Member]                      
License Collaboration And Manufacturing Agreements [Line Items]                      
Maximum potential milestone payments                 $ 556,000